AD patients exhibit significantly increased levels of NLRP3, caspase-1, GSDMD, and IL-1β in peripheral blood mononuclear cells, and in vivo studies have demonstrated that systemic inflammasome-induced cells exacerbate apoptosis [78]. This evidence concerns the gene NLRP3 and Alzheimer disease.